mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.064 |
0.8 |